ImmunoShield Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

ImmunoShield Therapeutics General Information

Description

Developer of regenerative medicine intended to deliver functional encapsulated cells to the patient safely. The company offers cell macro encapsulation technology and a method to induce antigen-specific immune tolerance, enabling clients to fabricate retrievable cell-laden devices protected from immune system recognition and to protect cell therapies from immune system rejection without chronic immunosuppression.

Contact Information

Website
www.immunoshieldtherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 275 North Gateway Drive
  • Suite 106
  • Phoenix, AZ 85034
  • United States
+1 (480)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 275 North Gateway Drive
  • Suite 106
  • Phoenix, AZ 85034
  • United States
+1 (480)

ImmunoShield Therapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunoShield Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Grant 01-Jan-2023 Completed Startup
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view ImmunoShield Therapeutics’s complete valuation and funding history, request access »

ImmunoShield Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmunoShield Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of Diabetes and Digestive and Kidney Diseases Government
Skysong Innovations Accelerator/Incubator
Center for Entrepreneurial Innovation Accelerator/Incubator
To view ImmunoShield Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

ImmunoShield Therapeutics FAQs

  • When was ImmunoShield Therapeutics founded?

    ImmunoShield Therapeutics was founded in 2021.

  • Where is ImmunoShield Therapeutics headquartered?

    ImmunoShield Therapeutics is headquartered in Phoenix, AZ.

  • What is the size of ImmunoShield Therapeutics?

    ImmunoShield Therapeutics has 3 total employees.

  • What industry is ImmunoShield Therapeutics in?

    ImmunoShield Therapeutics’s primary industry is Biotechnology.

  • Is ImmunoShield Therapeutics a private or public company?

    ImmunoShield Therapeutics is a Private company.

  • What is ImmunoShield Therapeutics’s current revenue?

    The current revenue for ImmunoShield Therapeutics is .

  • Who are ImmunoShield Therapeutics’s investors?

    National Institute of Diabetes and Digestive and Kidney Diseases, Skysong Innovations, and Center for Entrepreneurial Innovation have invested in ImmunoShield Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »